Kaken Pharmaceutical Co., Ltd. (TYO:4521)
Japan · Delayed Price · Currency is JPY 3,825.00
-15.00 (-0.39%)
Nov 13, 2026, 3:30 PM JST
Kaken Pharmaceutical Market Cap
Kaken Pharmaceutical has a market cap or net worth of 144.85 billion as of November 13, 2026. It is the 10,504th most valuable company in the world and the 792nd biggest in Japan. Its market cap has increased by 4.79% in one year.
Market Cap
144.85B
Enterprise Value
89.18B
Revenue
86.47B
Global Rank
Country Rank
#792 Japan
PE Ratio
15.83
ChartMarket Cap Chart
Since March 26, 1993, Kaken Pharmaceutical's market cap has increased from 118.38B to 144.85B, an increase of 22.36%. That is a compound annual growth rate of 0.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 144.85B | -4.73% |
| Dec 30, 2025 | 152.04B | -11.05% |
| Dec 30, 2024 | 170.93B | 34.53% |
| Dec 29, 2023 | 127.05B | -12.84% |
| Dec 30, 2022 | 145.77B | -8.45% |
| Dec 30, 2021 | 159.22B | 3.78% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tsumura & Co. | 291.77B |
| Nippon Shinyaku | 230.44B |
| Sawai Group Holdings | 192.15B |
| Towa Pharmaceutical | 166.42B |
| Kissei Pharmaceutical | 159.86B |
| Mochida Pharmaceutical | 117.66B |
| Zeria Pharmaceutical | 91.86B |
| ASKA Pharmaceutical Holdings | 62.30B |